In summary, targeting ALDH1L1 alone did not have an anti-cancer effect in the KrasLA2 lung cancer model, whereas simultaneous inhibition of ALDH1L1 and oxidative phosphorylation significantly decreased tumor formation. The gene discussed is ALDH1L1; the disease is lung carcinoma.